CON	Lives
AND	versus
CON	Profits
CON	NEW YORK
NIL	–
DEF	The
ORG	United States
ORG	Supreme
ORG	Court
IST	recently
EPS	began
CON	deliberations
REL	in
DIS	a
CON	case
AND	that
NOW	highlights
DIS	a
IST	deeply
IST	problematic
CON	issue
EXG	concerning
CON	intellectual-property
CON	rights
NIL	.
DEF	The
ORG	Court
NEC	must
EXS	answer
DEF	the
IST	following
CON	question
COO	:
POS	Can
IST	human
CON	genes
AND	–
HAS	your
CON	genes
NIL	–
EXS	be
IST	patented
QUE	?
EXS	Put
ALT	another
CON	way
NIL	,
NEC	should
DIS	someone
IST	essentially
EXS	be
EXS	permitted
REL	to
IST	own
DEF	the
CON	right
NIL	,
EXS	say
NIL	,
REL	to
CON	test
SUB	whether
PRO	you
NOW	have
DIS	a
CON	set
AND	of
CON	genes
SUB	that
EXS	imply
DIS	a
MOR	higher
MOR	than
QUC	50
UOM	%
CON	probability
AND	of
EXG	developing
CON	breast
CON	cancer
QUE	?
REL	To
DST	those
AND	outside
DEF	the
DEF	arcane
CON	world
AND	of
CON	intellectual-property
CON	rights
NIL	,
DEF	the
CON	answer
ENS	seems
EXS	obvious
NIL	:
NOT	No
NIL	.
PRO	You
NOW	own
HAS	your
CON	genes
NIL	.
DIS	A
CON	company
POS	might
IST	own
NIL	,
REL	at
TOP	most
NIL	,
DEF	the
IST	intellectual
CON	property
EXS	underlying
HAS	its
IST	genetic
CON	test
NIL	;
COO	and
NIL	,
SUB	because
DEF	the
CON	research
AND	and
CON	development
EPS	needed
SUB	to
EXS	develop
DEF	the
CON	test
POS	may
EXT	have
EXS	cost
DIS	a
IST	considerable
CON	amount
NIL	,
DEF	the
CON	firm
POS	might
IST	rightly
CON	charge
REL	for
EXS	administering
PRO	it
NIL	.
AND	But
DIS	a
IST	Utah-based
CON	company
NIL	,
ORG	Myriad
ORG	Genetics
NIL	,
ENS	claims
MOR	more
MOR	than
AND	that
NIL	.
PRO	It
ENS	claims
SUB	to
EXS	own
DEF	the
CON	rights
REL	to
AND	any
CON	test
REL	for
DEF	the
CON	presence
AND	of
DEF	the
QUC	two
IST	critical
CON	genes
EXS	associated
REL	with
CON	breast
CON	cancer
NIL	–
COO	and
NOW	has
IST	ruthlessly
EXS	enforced
SUB	that
EXS	right
NIL	,
SUB	though
HAS	their
CON	test
NOW	is
IST	inferior
REL	to
QUC	one
SUB	that
ORG	Yale
ORG	University
PST	was
IST	willing
SUB	to
EXS	provide
REL	at
QUV	much
MOR	lower
CON	cost
NIL	.
DEF	The
CON	consequences
NOW	have
PFT	been
IST	tragic
AND	:
IST	Thorough
EQU	,
IST	affordable
CON	testing
AND	that
NOW	identifies
IST	high-risk
CON	patients
ENS	saves
ENS	lives
NIL	.
CON	Blocking
AND	such
CON	testing
CON	costs
ENS	lives
NIL	.
GEO	Myriad
NOW	is
DIS	a
IST	true
CON	example
AND	of
DIS	an
GPO	American
CON	corporation
REL	for
UNK	which
CON	profit
CON	trumps
AND	all
ALT	other
CON	values
NIL	,
AND	including
DEF	the
CON	value
AND	of
IST	human
CON	life
REF	itself
NIL	.
PRX	This
DIS	a
INT	particularly
IST	poignant
CON	case
NIL	.
AND	Normally
NIL	,
CON	economists
EXS	talk
AND	about
CON	trade-offs
AND	:
MOR	weaker
CON	intellectual-property
CON	rights
NIL	,
PRO	it
NOW	is
EXS	argued
NIL	,
FUT	would
EXS	undermine
CON	incentives
SUB	to
EXS	innovate
NIL	.
DEF	The
CON	irony
PRX	here
NOW	is
SUB	that
GEO	Myriad
NOW	’s
CON	discovery
FUT	would
EXT	have
PFT	been
EXS	made
REL	in
AND	any
CON	case
NIL	,
EXS	owing
REL	to
DIS	a
IST	publicly
EXS	funded
NIL	,
IST	international
CON	effort
SUB	to
EXS	decode
DEF	the
IST	entire
IST	human
CON	genome
AND	that
PST	was
DIS	a
IST	singular
CON	achievement
AND	of
IST	modern
CON	science
NIL	.
DEF	The
IST	social
CON	benefits
AND	of
GEO	Myriad
NOW	’s
IST	slightly
AND	earlier
CON	discovery
NOW	have
PFT	been
EXS	dwarfed
REL	by
DEF	the
CON	costs
AND	that
HAS	its
CON	callous
CON	pursuit
AND	of
CON	profit
NOW	has
EXS	imposed
NIL	.
MOR	More
IST	broadly
NIL	,
UNK	there
EXG	is
EXG	increasing
CON	recognition
AND	that
DEF	the
CON	patent
CON	system
NIL	,
AND	as
IST	currently
EXS	designed
NIL	,
NOT	not
XCL	only
NOW	imposes
IST	untold
IST	social
CON	costs
NIL	,
COO	but
IST	also
ENS	fails
SUB	to
EXS	maximize
CON	innovation
NIL	–
AND	as
GEO	Myriad
NOW	’s
IST	gene
CON	patents
NOW	demonstrate
NIL	.
